| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 1.13e-06 | 31 | 121 | 5 | GO:0004181 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.16e-05 | 49 | 121 | 5 | GO:0004180 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.73e-05 | 26 | 121 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 1.78e-05 | 9 | 121 | 3 | GO:0016308 | |
| GeneOntologyMolecularFunction | tetrahydrofolyl-poly(glutamate) polymer binding | 3.64e-05 | 2 | 121 | 2 | GO:1904493 | |
| GeneOntologyMolecularFunction | Ac-Asp-Glu binding | 3.64e-05 | 2 | 121 | 2 | GO:1904492 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 6.64e-05 | 70 | 121 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 7.52e-05 | 14 | 121 | 3 | GO:0000340 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ATR STYK1 IRAK2 SNRK GCK GRK2 GRK3 PIK3C3 BRD4 PIP5K1B PIP4K2B PIPSL PLK4 CDK7 | 1.01e-04 | 709 | 121 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.09e-04 | 41 | 121 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 2.17e-04 | 4 | 121 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | kinase activity | ATR STYK1 IRAK2 SNRK GCK GRK2 GRK3 PIK3C3 BRD4 PIP5K1B PIP4K2B PIPSL PLK4 CDK7 | 2.19e-04 | 764 | 121 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | RNA cap binding | 2.67e-04 | 21 | 121 | 3 | GO:0000339 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.52e-04 | 23 | 121 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 5.54e-04 | 110 | 121 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 7.50e-04 | 7 | 121 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.06e-03 | 74 | 121 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.39e-03 | 200 | 121 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.59e-03 | 10 | 121 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ATR STYK1 IRAK2 SNRK GCK GRK2 GRK3 PIK3C3 BRD4 PIP5K1B PIP4K2B PIPSL PLK4 CDK7 | 1.64e-03 | 938 | 121 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | tRNA binding | 1.94e-03 | 87 | 121 | 4 | GO:0000049 | |
| GeneOntologyBiologicalProcess | C-terminal protein deglutamylation | 3.70e-06 | 6 | 119 | 3 | GO:0035609 | |
| GeneOntologyBiologicalProcess | protein deglutamylation | 1.03e-05 | 8 | 119 | 3 | GO:0035608 | |
| GeneOntologyBiologicalProcess | peptidyl-glutamic acid modification | 2.24e-05 | 29 | 119 | 4 | GO:0018200 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | DCAF6 ZBTB16 FOLH1 C10orf90 COPS3 BCL11A HUWE1 BIRC6 AGBL4 KLHL7 LTN1 CCAR1 FOLH1B MINAR1 HERC2 HERC6 ZNF738 LARGE1 | 4.33e-05 | 1074 | 119 | 18 | GO:0043687 |
| Domain | ARM-type_fold | ATR COPG2 HUWE1 ECPAS AP1G1 XPO5 PIK3C3 LTN1 TAF2 NIPBL AP3D1 | 1.19e-05 | 339 | 120 | 11 | IPR016024 |
| Domain | Cytoplasmic_FMR1-int | 4.09e-05 | 2 | 120 | 2 | IPR008081 | |
| Domain | FragX_IP | 4.09e-05 | 2 | 120 | 2 | PF05994 | |
| Domain | ARM-like | 6.24e-05 | 270 | 120 | 9 | IPR011989 | |
| Domain | RGS | 7.27e-05 | 35 | 120 | 4 | PF00615 | |
| Domain | RGS | 8.14e-05 | 36 | 120 | 4 | PS50132 | |
| Domain | HEAT_REPEAT | 8.73e-05 | 70 | 120 | 5 | PS50077 | |
| Domain | Clathrin/coatomer_adapt-like_N | 1.11e-04 | 15 | 120 | 3 | IPR002553 | |
| Domain | Adaptin_N | 1.11e-04 | 15 | 120 | 3 | PF01602 | |
| Domain | RGS | 1.12e-04 | 39 | 120 | 4 | IPR016137 | |
| Domain | Zn_pept | 1.97e-04 | 18 | 120 | 3 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_2 | 2.32e-04 | 19 | 120 | 3 | PS00133 | |
| Domain | DUF1394 | 2.44e-04 | 4 | 120 | 2 | PF07159 | |
| Domain | DUF1394 | 2.44e-04 | 4 | 120 | 2 | IPR009828 | |
| Domain | CARBOXYPEPT_ZN_1 | 2.72e-04 | 20 | 120 | 3 | PS00132 | |
| Domain | Peptidase_M14 | 4.17e-04 | 23 | 120 | 3 | PF00246 | |
| Domain | Peptidase_M14 | 4.17e-04 | 23 | 120 | 3 | IPR000834 | |
| Domain | - | 5.82e-04 | 222 | 120 | 7 | 1.25.10.10 | |
| Domain | TFR_dimer | 6.04e-04 | 6 | 120 | 2 | PF04253 | |
| Domain | - | 6.04e-04 | 6 | 120 | 2 | 1.20.930.40 | |
| Domain | HECT | 6.76e-04 | 27 | 120 | 3 | PF00632 | |
| Domain | HECTc | 6.76e-04 | 27 | 120 | 3 | SM00119 | |
| Domain | HECT_dom | 6.76e-04 | 27 | 120 | 3 | IPR000569 | |
| Domain | HECT | 6.76e-04 | 27 | 120 | 3 | PS50237 | |
| Domain | GPCR_kinase | 8.42e-04 | 7 | 120 | 2 | IPR000239 | |
| Domain | Anoct_dimer | 8.42e-04 | 7 | 120 | 2 | PF16178 | |
| Domain | Anoct_dimer | 8.42e-04 | 7 | 120 | 2 | IPR032394 | |
| Domain | PInositol-4-P-5-kinase | 8.42e-04 | 7 | 120 | 2 | IPR023610 | |
| Domain | TFR-like_dimer_dom | 8.42e-04 | 7 | 120 | 2 | IPR007365 | |
| Domain | PIPKc | 1.12e-03 | 8 | 120 | 2 | SM00330 | |
| Domain | - | 1.12e-03 | 8 | 120 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 1.12e-03 | 8 | 120 | 2 | PF01504 | |
| Domain | PIPK | 1.12e-03 | 8 | 120 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 1.12e-03 | 8 | 120 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 1.12e-03 | 8 | 120 | 2 | IPR027483 | |
| Domain | - | 1.12e-03 | 8 | 120 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 1.12e-03 | 8 | 120 | 2 | IPR002498 | |
| Domain | RGS | 1.46e-03 | 35 | 120 | 3 | SM00315 | |
| Domain | Anoctamin | 1.78e-03 | 10 | 120 | 2 | PF04547 | |
| Domain | Anoctamin | 1.78e-03 | 10 | 120 | 2 | IPR007632 | |
| Domain | Peptidase_M28 | 2.59e-03 | 12 | 120 | 2 | IPR007484 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.59e-03 | 12 | 120 | 2 | IPR013041 | |
| Domain | Peptidase_M28 | 2.59e-03 | 12 | 120 | 2 | PF04389 | |
| Domain | FERM-adjacent | 3.05e-03 | 13 | 120 | 2 | IPR014847 | |
| Domain | FA | 3.05e-03 | 13 | 120 | 2 | SM01195 | |
| Domain | FA | 3.05e-03 | 13 | 120 | 2 | PF08736 | |
| Domain | PH | 3.64e-03 | 229 | 120 | 6 | PF00169 | |
| Domain | - | 3.77e-03 | 391 | 120 | 8 | 2.30.29.30 | |
| Domain | PI3/4_kinase_CS | 4.07e-03 | 15 | 120 | 2 | IPR018936 | |
| Domain | - | 4.63e-03 | 16 | 120 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.63e-03 | 16 | 120 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 5.86e-03 | 18 | 120 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 5.86e-03 | 18 | 120 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 5.86e-03 | 18 | 120 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 5.86e-03 | 18 | 120 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.86e-03 | 18 | 120 | 2 | PS00916 | |
| Domain | HEAT | 6.17e-03 | 58 | 120 | 3 | IPR000357 | |
| Domain | PH_dom-like | 6.26e-03 | 426 | 120 | 8 | IPR011993 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | SIKE1 RPUSD4 NADSYN1 CYFIP1 PIK3C3 LTN1 CCAR1 HERC2 PIPSL CDK7 | 4.36e-09 | 212 | 122 | 10 | 33853758 |
| Pubmed | DHX16 COPG2 HUWE1 ECPAS BIRC6 PDIA4 XPO5 WDR6 CCAR1 DDX23 HERC2 RPL4 NIPBL HSPA9 HDAC2 | 1.05e-08 | 653 | 122 | 15 | 22586326 | |
| Pubmed | ZMYM2 COPG2 ECPAS NDUFS2 GTF3C5 CYFIP1 AP1G1 XPO5 WDR6 TUBGCP3 LTN1 DDX23 HSPA9 HDAC2 | 1.17e-08 | 560 | 122 | 14 | 35241646 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 12130708 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.36e-08 | 202 | 122 | 9 | 33005030 | |
| Pubmed | COPG2 HUWE1 ECPAS GTF3C5 CDC37 CYFIP1 AP1G1 XPO5 TUBGCP3 CCAR1 RPL4 AP3D1 HSPA9 HDAC2 | 5.89e-08 | 638 | 122 | 14 | 33239621 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 ATR COPS3 HUWE1 PPAT ECPAS NDUFS2 GTF3C5 CYFIP2 PDIA4 CDC37 CLPTM1L CYFIP1 AP1G1 XPO5 WDR6 CCAR1 RPL4 NIPBL HSPA9 | 1.22e-07 | 1425 | 122 | 20 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 COPS3 HUWE1 BIRC6 GTF3C5 CDC37 CYFIP1 AP1G1 WDR6 TUBGCP3 LTN1 CCAR1 DDX23 TAF2 HERC2 RPL4 NIPBL AP3D1 HSPA9 | 2.61e-07 | 1353 | 122 | 19 | 29467282 |
| Pubmed | PDE4A ZMYM2 GRIA4 BCL11A HUWE1 CYFIP2 BCL11B CYFIP1 LDB1 KLHL7 CCAR1 NAV1 HERC2 NIPBL HSPA9 HDAC2 | 2.80e-07 | 963 | 122 | 16 | 28671696 | |
| Pubmed | ATG2B ZMYM2 COPG2 HUWE1 ECPAS BIRC6 GTF3C5 WDR6 BRD4 NAV1 HDAC2 | 2.82e-07 | 418 | 122 | 11 | 34709266 | |
| Pubmed | COPG2 COPS3 HUWE1 PPAT ECPAS GTF3C5 PDIA4 CDC37 CLPTM1L AP1G1 XPO5 RPL4 HSPA9 EPB41 HDAC2 | 4.80e-07 | 878 | 122 | 15 | 37223481 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DHX16 HDHD5 COPG2 HUWE1 BIRC6 GTF3C5 CDC37 CYFIP1 AP1G1 LTN1 CCAR1 NIPBL AP3D1 | 1.25e-06 | 704 | 122 | 13 | 29955894 |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 30687000 | ||
| Pubmed | ZMYM2 COPS3 BCL11A PPAT ECPAS PDIA4 XPO5 BRD4 TUBGCP3 CCAR1 DDX23 ZNF770 NIPBL HSPA9 HDAC2 CDK7 | 1.66e-06 | 1103 | 122 | 16 | 34189442 | |
| Pubmed | COPG2 HUWE1 ECPAS BIRC6 NDUFS2 CDC37 CLPTM1L XPO5 TUBGCP3 LTN1 PTRH2 HERC2 | 3.66e-06 | 657 | 122 | 12 | 36180527 | |
| Pubmed | BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. | 4.96e-06 | 10 | 122 | 3 | 16091750 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZMYM2 COPS3 HUWE1 GTF3C5 BCL11B LDB1 CCAR1 RPL4 HSPA9 EPB41 HDAC2 | 7.01e-06 | 583 | 122 | 11 | 29844126 |
| Pubmed | ATG2B COPG2 ECPAS NDUFS2 PDIA4 CLPTM1L CYFIP1 XPO5 RPL4 AP3D1 HSPA9 EPB41 | 7.79e-06 | 708 | 122 | 12 | 39231216 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PPAT NDUFS2 CYFIP2 PDIA4 CYFIP1 ADAMTS20 DDX23 PIPSL RPL4 NIPBL AP3D1 HSPA9 HDAC2 | 9.26e-06 | 847 | 122 | 13 | 35235311 |
| Pubmed | 1.15e-05 | 396 | 122 | 9 | 26687479 | ||
| Pubmed | HDHD5 DDX60 COPG2 COPS3 HUWE1 MAP7 ECPAS NDUFS2 CDC37 CLPTM1L LDB1 XPO5 WDR6 LTN1 PTRH2 DDX23 AP3D1 | 1.18e-05 | 1440 | 122 | 17 | 30833792 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25872793 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27091009 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12196208 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 1.22e-05 | 2 | 122 | 2 | 38128786 | |
| Pubmed | Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. | 1.22e-05 | 2 | 122 | 2 | 8417812 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12712410 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26121690 | ||
| Pubmed | MidA is a putative methyltransferase that is required for mitochondrial complex I function. | 1.22e-05 | 2 | 122 | 2 | 20406883 | |
| Pubmed | BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange-like syndrome. | 1.22e-05 | 2 | 122 | 2 | 29379197 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 14716746 | ||
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 1.22e-05 | 2 | 122 | 2 | 10198406 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9691167 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31320616 | ||
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 1.22e-05 | 2 | 122 | 2 | 15465497 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31765738 | ||
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 1.22e-05 | 2 | 122 | 2 | 11762794 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23169655 | ||
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 1.22e-05 | 2 | 122 | 2 | 29752658 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22076974 | ||
| Pubmed | NDUFAF7 methylates arginine 85 in the NDUFS2 subunit of human complex I. | 1.22e-05 | 2 | 122 | 2 | 24089531 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11210180 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16190866 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19347959 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 8638670 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12358725 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26079448 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 33060647 | ||
| Pubmed | GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice. | 1.22e-05 | 2 | 122 | 2 | 39000003 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 8035170 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 1.22e-05 | 2 | 122 | 2 | 24357318 | |
| Pubmed | A novel PSMA/GCPII-deficient mouse model shows enlarged seminal vesicles upon aging. | 1.22e-05 | 2 | 122 | 2 | 30256431 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16809768 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30458729 | ||
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 1.22e-05 | 2 | 122 | 2 | 11719382 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12601556 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34327661 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9347959 | ||
| Pubmed | Early embryonic death of glutamate carboxypeptidase II (NAALADase) homozygous mutants. | 1.22e-05 | 2 | 122 | 2 | 14556233 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 35567753 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9838072 | ||
| Pubmed | The Rho exchange factor Net1 is regulated by nuclear sequestration. | 1.22e-05 | 2 | 122 | 2 | 11839749 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31324746 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37543278 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | COPG2 COPS3 HUWE1 MAP7 ECPAS GTF3C5 CYFIP2 PDIA4 CDC37 CYFIP1 XPO5 RPL4 AP3D1 HSPA9 HDAC2 | 1.26e-05 | 1149 | 122 | 15 | 35446349 |
| Pubmed | DHX16 MAP7 BIRC6 PDIA4 CDC37 CLPTM1L CYFIP1 XPO5 PIK3C3 WDR6 CCAR1 RPL4 NIPBL AP3D1 HSPA9 CDK7 | 1.28e-05 | 1297 | 122 | 16 | 33545068 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ZBTB16 COPG2 MAP7 ECPAS PDIA4 BRD4 TUBGCP3 LTN1 CCAR1 HERC2 HDAC2 EIF4E2 | 1.46e-05 | 754 | 122 | 12 | 33060197 |
| Pubmed | HUWE1 ECPAS BIRC6 CYFIP2 CLPTM1L GRK2 AGO4 AP1G1 PIK3C3 PLXNC1 TUBGCP3 PTRH2 HERC2 RPL4 AP3D1 | 1.53e-05 | 1168 | 122 | 15 | 19946888 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HDHD5 ATG2B HUWE1 PPAT BIRC6 NDUFS2 PDIA4 CDC37 CLPTM1L RPUSD4 WDR6 NDUFAF7 PTRH2 NAV1 HERC2 RPL4 HSPA9 | 1.93e-05 | 1496 | 122 | 17 | 32877691 |
| Pubmed | NET1 ZMYM2 COPG2 MAP7 NDUFS2 CYFIP2 CLPTM1L CYFIP1 AP1G1 LTN1 PTRH2 CCAR1 TAF2 HERC2 NIPBL EPB41 CDK7 | 1.94e-05 | 1497 | 122 | 17 | 31527615 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 ZMYM2 NDUFS2 GTF3C5 SULF2 BRD4 TUBGCP3 CCAR1 DDX23 SRPX RPL4 NIPBL AP3D1 HDAC2 | 2.77e-05 | 1082 | 122 | 14 | 38697112 |
| Pubmed | 3.25e-05 | 103 | 122 | 5 | 32744500 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 10754297 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 22815987 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 37349952 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 10085131 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 3.65e-05 | 3 | 122 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 3.65e-05 | 3 | 122 | 2 | 31604529 | |
| Pubmed | Biochemical characterization of human glutamate carboxypeptidase III. | 3.65e-05 | 3 | 122 | 2 | 17241121 | |
| Pubmed | Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair. | 3.65e-05 | 3 | 122 | 2 | 23178497 | |
| Pubmed | Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family. | 3.65e-05 | 3 | 122 | 2 | 17160644 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 30463877 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 38377674 | ||
| Pubmed | Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3. | 3.65e-05 | 3 | 122 | 2 | 21908619 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 36640195 | ||
| Pubmed | Regulation of pulmonary fibrosis by chemokine receptor CXCR3. | 3.65e-05 | 3 | 122 | 2 | 15254596 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HDHD5 HUWE1 MAP7 BIRC6 NDUFS2 CYFIP1 AP1G1 PTRH2 NAV1 DDX23 RPL4 NIPBL AP3D1 HSPA9 HDAC2 EIF4E2 | 3.67e-05 | 1415 | 122 | 16 | 28515276 |
| Pubmed | DCAF6 C5orf22 NET1 BCL11A MAP7 BCL11B SULF2 WDR6 BRD4 TUBGCP3 LTN1 PIP4K2B TAF2 HDAC2 | 3.87e-05 | 1116 | 122 | 14 | 31753913 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | C5orf22 HUWE1 ECPAS PDIA4 CDC37 CYFIP1 XPO5 WDR6 LTN1 PTRH2 DUSP10 PIPSL RPL4 | 3.97e-05 | 974 | 122 | 13 | 28675297 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.11e-05 | 582 | 122 | 10 | 20467437 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SNRK COPG2 COPS3 ECPAS DEGS1 PDIA4 CDC37 XPO5 PIK3C3 CCNA1 DDX23 PIP5K1B HERC2 EPB41 EIF4E2 | 4.54e-05 | 1284 | 122 | 15 | 17353931 |
| Pubmed | 4.67e-05 | 591 | 122 | 10 | 15231748 | ||
| Pubmed | ATG2B GRIA4 SNRK CPZ HUWE1 BIRC6 NDUFS2 GRK2 NAV1 PIP4K2B HSPA9 EPB41 SHISA6 HDAC2 | 4.82e-05 | 1139 | 122 | 14 | 36417873 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DHX16 DCAF6 ZMYM2 COPS3 GTF3C5 PDIA4 NDUFAF7 TUBGCP3 CCAR1 DDX23 HERC2 NIPBL PLK4 HDAC2 | 5.60e-05 | 1155 | 122 | 14 | 20360068 |
| Pubmed | 5.60e-05 | 604 | 122 | 10 | 38803224 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DHX16 ERICH1 ZMYM2 GTF3C5 BRD4 ZNF770 TAF2 HERC2 NIPBL HDAC2 | 5.92e-05 | 608 | 122 | 10 | 36089195 |
| Pubmed | DHX16 ATR ECPAS GTF3C5 CDC37 XPO5 BRD4 CCAR1 DDX23 TAF2 NIPBL HDAC2 CDK7 | 5.97e-05 | 1014 | 122 | 13 | 32416067 | |
| Pubmed | 6.50e-05 | 383 | 122 | 8 | 29331416 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 6.56e-05 | 495 | 122 | 9 | 28581483 | |
| Pubmed | 6.67e-05 | 496 | 122 | 9 | 31343991 | ||
| Interaction | SIRT7 interactions | DHX16 ATR COPG2 HUWE1 ECPAS BIRC6 PDIA4 XPO5 WDR6 BRD4 CCAR1 DDX23 HERC2 RPL4 NIPBL HSPA9 HDAC2 | 1.39e-06 | 744 | 117 | 17 | int:SIRT7 |
| Interaction | HDGFL2 interactions | 1.99e-06 | 194 | 117 | 9 | int:HDGFL2 | |
| Interaction | LRRC31 interactions | 3.13e-06 | 205 | 117 | 9 | int:LRRC31 | |
| Interaction | C9orf78 interactions | ZMYM2 COPG2 ECPAS NDUFS2 GTF3C5 CYFIP1 AP1G1 XPO5 WDR6 TUBGCP3 LTN1 DDX23 HSPA9 HDAC2 | 1.46e-05 | 620 | 117 | 14 | int:C9orf78 |
| Interaction | ARRDC2 interactions | 1.53e-05 | 54 | 117 | 5 | int:ARRDC2 | |
| Interaction | BACC1 interactions | 3.21e-05 | 104 | 117 | 6 | int:BACC1 | |
| Interaction | MYH10 interactions | 4.68e-05 | 359 | 117 | 10 | int:MYH10 | |
| Interaction | AR interactions | DCAF6 ZBTB16 FOLH1 ZMYM2 HUWE1 ECPAS CDC37 CYFIP1 LDB1 XPO5 BRD4 CCAR1 DDX23 NIPBL HSPA9 HDAC2 CDK7 | 5.86e-05 | 992 | 117 | 17 | int:AR |
| Interaction | MAP1LC3C interactions | 6.21e-05 | 72 | 117 | 5 | int:MAP1LC3C | |
| Interaction | GAS7 interactions | 6.84e-05 | 38 | 117 | 4 | int:GAS7 | |
| Interaction | NR2E1 interactions | 6.84e-05 | 38 | 117 | 4 | int:NR2E1 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | DHX16 NET1 DDX60 CYFIP2 PDIA4 PLXNC1 LTN1 PIP4K2B HDAC2 EIF4E2 | 6.54e-06 | 367 | 118 | 10 | M41159 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | NET1 COPS3 MAP7 PPAT DEGS1 CDC37 LDB1 PIK3C3 PLXNC1 TUBGCP3 DDX23 PIP5K1B TAF2 ARHGEF3 HSPA9 EPB41 HDAC2 EIF4E2 CDK7 | 1.55e-05 | 1399 | 118 | 19 | M535 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 2.27e-05 | 187 | 118 | 7 | M6807 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 3.28e-05 | 198 | 118 | 7 | M6114 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN | 3.50e-05 | 200 | 118 | 7 | M5096 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | DCAF6 ATR SNRK BCL11A NDUFS2 DEGS1 BCL11B LTN1 PTRH2 CCNA1 OSBPL10 PIP5K1B ARHGEF3 HERC2 HSPA9 CDK7 LARGE1 | 4.40e-05 | 1248 | 118 | 17 | M17728 |
| Coexpression | GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP | 5.52e-05 | 147 | 118 | 6 | M6918 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | 2.53e-07 | 79 | 116 | 7 | GSM538265_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | 3.74e-06 | 76 | 116 | 6 | GSM538248_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3 | 3.74e-06 | 76 | 116 | 6 | GSM538249_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1 | 4.03e-06 | 77 | 116 | 6 | GSM605839_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | 4.35e-06 | 78 | 116 | 6 | GSM538266_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2 | 5.05e-06 | 80 | 116 | 6 | GSM605837_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11blo.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b-, Lymph Node, avg-3 | 5.83e-06 | 82 | 116 | 6 | GSM538277_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 5.83e-06 | 82 | 116 | 6 | GSM538242_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 6.25e-06 | 83 | 116 | 6 | GSM854285_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 5.32e-05 | 74 | 116 | 5 | GSM538245_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | 5.68e-05 | 75 | 116 | 5 | GSM605826_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3 | 6.85e-05 | 78 | 116 | 5 | GSM538274_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1 | 8.21e-05 | 81 | 116 | 5 | GSM854290_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1 | 1.15e-04 | 87 | 116 | 5 | GSM538262_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.67e-04 | 229 | 116 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.02e-08 | 177 | 121 | 8 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-07 | 186 | 121 | 7 | 305f1726b8b5add32f1c29c74991ff34f42e0da7 | |
| ToppCell | Biopsy_Other_PF-Immune-pDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.15e-06 | 197 | 121 | 7 | 598a130eb7afb1bb95da64a964218362627feb49 | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-06 | 198 | 121 | 7 | b21227c7366ef79b36048509a91d2d35fd5e4956 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-06 | 200 | 121 | 7 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-06 | 149 | 121 | 6 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.21e-06 | 155 | 121 | 6 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 7.39e-06 | 171 | 121 | 6 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 7.39e-06 | 171 | 121 | 6 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.39e-06 | 171 | 121 | 6 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.90e-06 | 180 | 121 | 6 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.90e-06 | 180 | 121 | 6 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 9.90e-06 | 180 | 121 | 6 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 183 | 121 | 6 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 183 | 121 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.19e-05 | 186 | 121 | 6 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 121 | 6 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 121 | 6 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 121 | 6 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 188 | 121 | 6 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 188 | 121 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.31e-05 | 189 | 121 | 6 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.35e-05 | 190 | 121 | 6 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 121 | 6 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.39e-05 | 191 | 121 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 192 | 121 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 1.47e-05 | 193 | 121 | 6 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 194 | 121 | 6 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-05 | 194 | 121 | 6 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-05 | 194 | 121 | 6 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.51e-05 | 194 | 121 | 6 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 195 | 121 | 6 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.61e-05 | 196 | 121 | 6 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.61e-05 | 196 | 121 | 6 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 1.65e-05 | 197 | 121 | 6 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 1.70e-05 | 198 | 121 | 6 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 1.70e-05 | 198 | 121 | 6 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 1.70e-05 | 198 | 121 | 6 | 90f3b227cbc61c268d6d94bc9945a08d83d2d3d5 | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 121 | 6 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | 26ea06960e8ea061a71756750b84489609f78162 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.80e-05 | 200 | 121 | 6 | ef42753c9fbe3770e3f415cd7ab412654d359edb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.73e-05 | 129 | 121 | 5 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.47e-05 | 143 | 121 | 5 | bb8d4c335682d1a6798bed0de8bb0603054a4944 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.98e-05 | 152 | 121 | 5 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-05 | 153 | 121 | 5 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.39e-05 | 159 | 121 | 5 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.62e-05 | 160 | 121 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.84e-05 | 161 | 121 | 5 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.84e-05 | 161 | 121 | 5 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.08e-05 | 162 | 121 | 5 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 8.81e-05 | 165 | 121 | 5 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.81e-05 | 165 | 121 | 5 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.32e-05 | 167 | 121 | 5 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.32e-05 | 167 | 121 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 167 | 121 | 5 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.32e-05 | 167 | 121 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.59e-05 | 168 | 121 | 5 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.75e-05 | 88 | 121 | 4 | 2075743c7c0b6d74e80464a6bc776206d744d502 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.75e-05 | 88 | 121 | 4 | a49319bc97188550e08248973e10c626124c3917 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.75e-05 | 88 | 121 | 4 | 14b11249a2b3fa327622897fe74630c2697ea47e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-05 | 169 | 121 | 5 | e7470a5b060881b2a8ce2ab04b0788396aa13889 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 170 | 121 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 170 | 121 | 5 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 170 | 121 | 5 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 170 | 121 | 5 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 89 | 121 | 4 | 56039e126e6f3e8fcaf3c47237c980e514512536 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.04e-04 | 171 | 121 | 5 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pDC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 173 | 121 | 5 | b571970e3ba88afc07041c5692ccfd85fc39e796 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-04 | 174 | 121 | 5 | 991f7eab69ea3ee1045a4e44ce60a96db13df6d1 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-04 | 174 | 121 | 5 | c8cec89369cf3896c5626e447051e76a142cb6df | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.13e-04 | 174 | 121 | 5 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | 84d91843b34504636d5af6bda9930031409a1627 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | 2368aa8318ab83e0e0fd539a17264f9e1d755cf1 | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 176 | 121 | 5 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.22e-04 | 177 | 121 | 5 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 177 | 121 | 5 | 4d67e24653caa318039870114849426ff2582e0c | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 177 | 121 | 5 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 1.22e-04 | 177 | 121 | 5 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.26e-04 | 178 | 121 | 5 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | NS-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-04 | 179 | 121 | 5 | c044478525b8e7eedecddb924c1b049331180cb2 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.29e-04 | 179 | 121 | 5 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 5fdd10ffdf49f0e818f865ca095a3882b35c640e | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.39e-04 | 182 | 121 | 5 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 182 | 121 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.43e-04 | 183 | 121 | 5 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 1.43e-04 | 183 | 121 | 5 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 184 | 121 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.47e-04 | 184 | 121 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 1.47e-04 | 184 | 121 | 5 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 1.51e-04 | 185 | 121 | 5 | 23ffba9216729b5bdb30b35742ba2627bb1200bf | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.54e-04 | 186 | 121 | 5 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 186 | 121 | 5 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.54e-04 | 186 | 121 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.54e-04 | 186 | 121 | 5 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 1.54e-04 | 186 | 121 | 5 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.54e-04 | 186 | 121 | 5 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | normal_Lung-Myeloid_cells-CD141+_DCs|normal_Lung / Location, Cell class and cell subclass | 1.54e-04 | 186 | 121 | 5 | a6698a2f4edd81b67e06531ede0e207dd0309205 | |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.54e-04 | 186 | 121 | 5 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 1.54e-04 | 186 | 121 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 4.74e-05 | 3 | 118 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 6.59e-05 | 105 | 118 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 1.57e-04 | 5 | 118 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 1.57e-04 | 5 | 118 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 1.57e-04 | 5 | 118 | 2 | C4551851 | |
| Disease | De Lange syndrome | 2.35e-04 | 6 | 118 | 2 | cv:C0270972 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.68e-04 | 670 | 118 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | Cornelia De Lange Syndrome | 4.37e-04 | 8 | 118 | 2 | C0270972 | |
| Disease | bacterial pneumonia (is_marker_for) | 5.60e-04 | 9 | 118 | 2 | DOID:874 (is_marker_for) | |
| Disease | executive function measurement | 8.11e-04 | 376 | 118 | 7 | EFO_0009332 | |
| Disease | airway wall thickness measurement | 1.02e-03 | 12 | 118 | 2 | EFO_0006898 | |
| Disease | Myeloproliferative disease | 1.02e-03 | 12 | 118 | 2 | C0027022 | |
| Disease | Replication Error Phenotype | 1.61e-03 | 15 | 118 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 1.61e-03 | 15 | 118 | 2 | C0920269 | |
| Disease | puberty onset measurement | 1.62e-03 | 125 | 118 | 4 | EFO_0005677 | |
| Disease | autism spectrum disorder (is_implicated_in) | 1.83e-03 | 16 | 118 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | ovarian carcinoma | 1.88e-03 | 321 | 118 | 6 | EFO_0001075 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.02e-03 | 566 | 118 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | hyperglycemia (implicated_via_orthology) | 2.07e-03 | 17 | 118 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | pulmonary surfactant-associated protein d measurement | 2.33e-03 | 18 | 118 | 2 | EFO_0020693 | |
| Disease | Myeloid Leukemia | 2.33e-03 | 18 | 118 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.33e-03 | 18 | 118 | 2 | C0023466 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.78e-03 | 145 | 118 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.87e-03 | 20 | 118 | 2 | DOID:3328 (is_marker_for) | |
| Disease | hemorrhoid | 2.92e-03 | 147 | 118 | 4 | EFO_0009552 | |
| Disease | Prostatic Neoplasms | 3.39e-03 | 616 | 118 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.39e-03 | 616 | 118 | 8 | C0376358 | |
| Disease | Seckel syndrome | 3.48e-03 | 22 | 118 | 2 | C0265202 | |
| Disease | Primary microcephaly | 3.48e-03 | 22 | 118 | 2 | C0431350 | |
| Disease | waist-hip ratio | ARPP21 CALCR BCL11A BIRC6 OPRL1 NEDD9 AGBL4 ADAMTS20 PIP4K2B PIPSL AP3D1 SHISA6 | 3.73e-03 | 1226 | 118 | 12 | EFO_0004343 |
| Disease | schizophrenia (is_implicated_in) | 3.81e-03 | 78 | 118 | 3 | DOID:5419 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLPSDVSILYHMKTL | 381 | Q86X53 | |
| KVMELHKSYRSMTPA | 366 | P11171 | |
| VSYLMAMEKSKATPA | 11 | P35626 | |
| KAYHDPMLKLSIMTE | 146 | Q9NR81 | |
| HRKLNAVTKEMEPYM | 436 | Q75V66 | |
| KASTVHMMLQPILTY | 3046 | Q9NR09 | |
| TPAMAVSHIMLESYK | 211 | Q9UNS2 | |
| VMATKMAALHYPSTT | 791 | Q14511 | |
| HPMDMSTIKSKLEAR | 396 | O60885 | |
| HMYLKAVKATMILVP | 336 | P30988 | |
| ADHLYSAKVMLMASP | 441 | Q8IX12 | |
| MVYKGHRNSRTMIKE | 711 | Q58WW2 | |
| DSVEPMFKHLKMTYV | 491 | Q9HCK5 | |
| DPMLSKMILASEKYS | 821 | O60231 | |
| LEHYMASLMPLQKSI | 431 | Q8NEG7 | |
| TYKSDPAMRKMLNHL | 216 | Q8N4T0 | |
| KKFPQMSSYQRMLVH | 186 | Q9UBL0 | |
| YCSKEMPRKAHSNML | 1666 | Q96BY7 | |
| EMKVTKYHVMAPALS | 421 | P59510 | |
| DVRSPESHITYKMMK | 396 | Q8IWF9 | |
| VSYLMAMEKSKATPA | 11 | P25098 | |
| IMTLMSHTKPYIRKK | 151 | O14617 | |
| KAYLRSMIPHLESGM | 51 | Q08116 | |
| VKTKHQMYSIPEDAM | 101 | P35557 | |
| SVYHMTLKDLPAMVR | 1566 | O94822 | |
| ARKAYHDPMLKLSIM | 196 | Q7Z628 | |
| KKYDHMRSALLERMP | 571 | O43747 | |
| NRMYLTPSEKHMLLK | 251 | Q7L576 | |
| VMYMAPKSSHSQERR | 256 | Q8NGT7 | |
| LRNVAMKHISTPYMF | 546 | O95461 | |
| IKTTMRYHLTPVRMA | 1106 | O00370 | |
| IIMPYKAAHSRNSMD | 256 | Q14244 | |
| PMQELMSRHKTYSLS | 251 | Q86U70 | |
| AHLCPVNKRSKYTMM | 356 | O43187 | |
| KYTMMKTHLLRTSAA | 366 | O43187 | |
| HRLKMIVDPADSSYM | 2831 | O95714 | |
| IYSISMKHPQEMKTY | 611 | Q04609 | |
| MKHPQEMKTYSVSFD | 616 | Q04609 | |
| KMPFSVYSTLEKHMK | 806 | Q9H165 | |
| QVMKRIHSLMEKYSE | 671 | Q8IY21 | |
| ATIVIAYLMKHTRMT | 416 | Q9Y6W6 | |
| EKASHRMKTPVKYMT | 566 | Q5VYK3 | |
| TIMESPYVMYKKNHE | 421 | P48058 | |
| DTHMKFSLPSSRKEM | 716 | O60486 | |
| YRSVSEMASHKFKRM | 251 | P27815 | |
| VLPRSMRMHFTYDLK | 191 | O14986 | |
| ISMKHPQEMKTYSLS | 306 | Q9HBA9 | |
| HNILSLPKYSTMERM | 986 | Q8IVU3 | |
| VKHAMTMQPYLTTKC | 2021 | Q6KC79 | |
| LSKPQMIMYKTNSSH | 51 | H3BRN8 | |
| HPMMSKETRQSKLAE | 36 | A8MZA4 | |
| HDKYTLRKSMIPSFM | 461 | Q96CW5 | |
| KMVISGMRYHLLSPE | 261 | Q8IXQ5 | |
| MPTKKMYHINETRGL | 176 | Q5XXA6 | |
| NKMYLTPSEKHMLLK | 251 | Q96F07 | |
| KHKYRQTVMFTATMP | 596 | Q9BUQ8 | |
| IAKPLHYVTMMRKEV | 126 | Q8NGJ1 | |
| ASLKSNYNLPMHKMI | 271 | P36578 | |
| YLTMDSSGPKHLNMK | 331 | P38646 | |
| MYSIPKDKQMLLFTH | 246 | Q7Z6Z7 | |
| MTVKTLHGPAMVKYL | 1 | Q96PD4 | |
| PKRAEMKTSMESLIH | 366 | O75306 | |
| MNNLLPRSVKMHIKY | 191 | A2A3N6 | |
| KSIFKQMKTHPPYTM | 91 | A2A2Y4 | |
| QMKTHPPYTMCFRVK | 96 | A2A2Y4 | |
| IMMKHDFKVTIYLLP | 1516 | Q13535 | |
| MPFSVYSTLEKHMKK | 861 | Q9C0K0 | |
| FKLLSRAYADVHPMM | 411 | Q66K79 | |
| ISKMDPTDAKYHMQR | 321 | Q16543 | |
| SLVLTPSHIKAYMLM | 106 | P50613 | |
| LRNYKAKMPSHLMLA | 311 | Q8ND61 | |
| HYMKKQPDITEGMRT | 231 | P78396 | |
| SLKKRMEVPDYEMVH | 341 | Q49AR2 | |
| TKSLYRDGMAPMVKS | 106 | Q5VU57 | |
| VMDDTISPYSRMKRH | 301 | O15121 | |
| ISPYSRMKRHQKGEM | 306 | O15121 | |
| VSSLHMMKISYDVVK | 161 | Q9UBF2 | |
| LCQKYPRKHSVMMTF | 386 | Q9UBF2 | |
| LRVHSYKSMQPEMDR | 511 | Q8IY82 | |
| KMEIYRPHKATAEEM | 51 | Q92769 | |
| IMEYKTHTDSIKMPG | 211 | O60573 | |
| DSSSYLTPMKHMLAA | 81 | Q70HW3 | |
| RHLTMIKMRPYDANK | 136 | Q99500 | |
| MYIRPSSSHSMDTDK | 256 | Q8NGF7 | |
| LVMYVILRHTKMKTA | 71 | P41146 | |
| SLKAHMKSNPLYTDM | 801 | Q9UPX6 | |
| ETRMYPKLSGLHRSM | 871 | Q8NEY1 | |
| HKMTLSPSYRMDDGK | 216 | Q96CM3 | |
| LPNFYTHTKMTMAKE | 191 | A5PLK6 | |
| SSLEKDMHYAKISSM | 306 | A5PLK6 | |
| KAFVSRYKLMRHMAT | 41 | Q9UM63 | |
| RYKLMRHMATHSPQK | 46 | Q9UM63 | |
| TPMLRHLMYKIKSTG | 41 | Q7L592 | |
| KAEMLHMYSQKDPLI | 321 | Q8WUX1 | |
| THDMRKKTFHYMLTI | 226 | Q6P1X5 | |
| MKSHESSPKKEVYFM | 351 | P78356 | |
| SPMKLFSEYHEKRML | 121 | Q9BXW7 | |
| PKTHEMYLNVMRRFS | 511 | Q8NEB9 | |
| MKDMSKYKPHILLSQ | 61 | Q9BRV8 | |
| VSTPVLDRYRMSKMH | 431 | Q6ZSJ9 | |
| AMLLYKTMTRPKHFL | 806 | Q8WX94 | |
| MVILTYLDSKLHTPM | 51 | Q8NGG5 | |
| EKFQSKYEPRSHMMD | 361 | P13667 | |
| KHGMDKERYVSLVMP | 421 | P78539 | |
| NTMKYMTALHSKPEI | 541 | O00444 | |
| MIMDCKYTVPSHVSK | 226 | Q9NRH2 | |
| KYHMEMNSKSAPSSR | 171 | Q9BXB5 | |
| HFTAMPKLLSYRMKK | 136 | Q16533 | |
| DGSSLPADVHRYMKM | 186 | Q96KA5 | |
| KEMHMRSKRIYDNLP | 646 | Q96M02 | |
| KRPSSCTHTMYSIMK | 346 | Q6J9G0 | |
| MPSKSLVMEYLAHPS | 1 | Q9Y3E5 | |
| MKRHSMVATPPVTYS | 96 | Q8NE65 | |
| YPSMKKAIAHAMKVA | 496 | A6PVC2 | |
| TEYCPSLSSMQKHMK | 636 | Q05516 | |
| AEMKTYSHRTMPSAC | 21 | P35247 | |
| MPVIMKNSVYIHKAA | 416 | A6NEE1 | |
| LMKEAPTAYSLLIMH | 176 | Q06203 | |
| RTHNTLYAPEMLAKM | 781 | Q9HAV4 | |
| LMYSRRHSQKKVPMM | 476 | A0A0J9YWL9 | |
| HRMVKVDPETRYMSL | 851 | Q9NNW5 | |
| LHPCSKSDPMYSMKR | 141 | Q6IQ21 | |
| KSDPMYSMKRRKNIH | 146 | Q6IQ21 | |
| TMTKATYCKPHMQTK | 856 | Q9UBW7 | |
| SRKRKSMPTKMPYNH | 76 | Q8N895 | |
| KHTSMYDKVLMLRPE | 141 | Q9Y5Q8 | |
| LSMTHYMSKKELSRL | 131 | Q6PF06 | |
| KSHRPIFENSMDKMY | 456 | Q9NWH7 | |
| TSKKMYPHRPVLMVI | 206 | Q8IWU5 | |
| MLYKSSDRPAHKVSM | 1 | Q8NI32 | |
| SKYSMNRHKMTTLTP | 641 | Q6IA69 |